These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4537955)

  • 1. Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa.
    Nath K; Agarwal SN; Mittal HS; Singh KN; Saxena S; Pant H
    J Indian Med Assoc; 1972 Apr; 58(7):242-5. PubMed ID: 4537955
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of guanethidine and methyldopa on a standardized test for renin responsiveness.
    Lowder SC; Liddle GW
    Ann Intern Med; 1975 Jun; 82(6):757-60. PubMed ID: 1138585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Glezer GA
    Kardiologiia; 1968 Aug; 8(8):113-8. PubMed ID: 5727457
    [No Abstract]   [Full Text] [Related]  

  • 4. The reversibility of side effects of guanethidine therapy.
    Bauer GE; Hull RD; Stokes GS; Raftos J
    Med J Aust; 1973 May; 1(19):930-3. PubMed ID: 4736691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative evaluation of the therapeutic effect and mechanism of action of isobarin and aldomet in hypertension].
    Erina EV; Zamyslova KN; Il'ina LI; Glezer GA; Pershakova LP; Vyshnepol'skiĭ IuIa; Labeeva TN
    Kardiologiia; 1967 Mar; 7(3):35-41. PubMed ID: 4883577
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion of 5-hydroxyindoleacetic acid in the urine of sarcoma-45 bearing rats after administration of serotonin, 5-hydroxytryptophan and tryptophan].
    Mal'tseva LF; Brazhnikova ID; Rudzit EA
    Vopr Med Khim; 1968; 14(2):150-2. PubMed ID: 5303056
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of severe hypertension with a combination of methyldopa and guanethidine.
    Datey KK; Nanda NC; Dalvi CP
    J Assoc Physicians India; 1965 Sep; 13(9):707-9. PubMed ID: 5840518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methyldopa, clonidine and guanethidine in the treatment of hypertension].
    Cottier P; Seiler A
    Ther Umsch; 1976 May; 33(5):326-35. PubMed ID: 1006592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride].
    Montoreano F; Abrahim H; Plotquin J
    Prensa Med Argent; 1966 Jun; 53(22):1248-51. PubMed ID: 5968337
    [No Abstract]   [Full Text] [Related]  

  • 10. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. II. Applications and drug studies.
    Eccleston D; Ashcroft GW; Crawford TB
    J Neurochem; 1965 Jun; 12(6):493-503. PubMed ID: 5294373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the hemodynamic effects of clonidine, alpha-methyldopa, guanethidine and reserpine: preliminary study].
    Merceron R; Weiss Y; Safar M; Milliez P
    Therapie; 1973; 28(1):93-101. PubMed ID: 4731486
    [No Abstract]   [Full Text] [Related]  

  • 13. Methyldopa in hypertension.
    Br Med J; 1966 Jan; 1(5480):119-20. PubMed ID: 5901568
    [No Abstract]   [Full Text] [Related]  

  • 14. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance and demonstration methods of increased 5-hydroxyindoleacetic acid excretion in the urine].
    Kirberger E
    Dtsch Med Wochenschr; 1966 Nov; 91(47):2128-30. PubMed ID: 5297243
    [No Abstract]   [Full Text] [Related]  

  • 16. The comparative effects of guanethidine and alpha-methyl dopa on the digital circulation in hypertension.
    Naftchi NE; Mendlowitz M; Wolf RL; Gitlow SE
    Bibl Anat; 1965; 7():572-8. PubMed ID: 5860794
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothermia dn alphamethyldopa treatment.
    Chandramohan M; Hariharasubramanian N; Johnson ES; Devi SP
    Indian J Physiol Pharmacol; 1976; 20(4):216-20. PubMed ID: 1010637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems of essential hypertension].
    Latotzki H
    Z Arztl Fortbild (Jena); 1965 Nov; 59(22):1196-9. PubMed ID: 5888328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autocontrol of blood pressure in severe hypertension?].
    Magnus KE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(40):1772-7. PubMed ID: 5069860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.